Berenberg Bank analyst Luisa Hector maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €115.00.

The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for ...

The proposal from PAI Partners, challenging a US bidder, is the latest twist in a battle to win a 50% stake in Opella, the ...

A consortium led by French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health ...

In a report released yesterday, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the ...

France's CGT and CFDT unions have called on workers at pharma company Sanofi to strike from Thursday to show their protest ...

In a powerful demonstration of high-level support, the World Health Organization (WHO) today received nearly US$ 700 million in new funding commitments from European countries, foundations and others, ...

The full content of this article is only available to NamNews Subscribers. If you are an existing subscriber, please log in below. Any problems logging in, contact us here ...

Sanofi SA is in talks to sell a 50% controlling stake in its consumer health unit to Clayton Dubilier & Rice, in what is set ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...